{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:17Z","timestamp":1790638577649,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":132,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Parkinson's Disease"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The purpose of this trial was to evaluate preliminary efficacy and safety of multiple intravenous infusions of autologous, Hope Biosciences adipose\u2010derived mesenchymal stem cells (HB\u2010adMSCs) for the treatment of patients with Parkinson\u2019s disease (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200924 patients with PD were randomized 5:3 into HB\u2010adMSC (200 million) or Placebo. Six intravenous infusions of HB\u2010adMSCs or saline were administered at Weeks 0, 4, 8, 16, 24, and 32 with a follow\u2010up at Week 42 and the end of study (EOS) at Week 52. The primary efficacy endpoint was to investigate change from baseline to Week 52 in Movement Disorder Society\u2010Unified Parkinson\u2019s Disease Rating Scale (MDS\u2010UPDRS) Part II. Primary safety endpoints included the incidence of adverse and serious adverse events (AE\/SAEs) and clinically significant changes in laboratory assessments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HB\u2010adMSC treatment was well tolerated and safe, with only one SAE reported, which was deemed unrelated to the investigational product. In total, 81 AEs were recorded, 79 of which were mild, one moderate, and one severe. Neurological disorders were the most commonly reported AEs, with a higher incidence in the placebo group (66.7%) compared with the HB\u2010adMSC group (46.7%). No deaths occurred, and no clinically meaningful changes were observed in laboratory parameters from baseline to the EOS for either group. Efficacy analyses revealed no clear treatment effect in MDS\u2010UPDRS II scores between the HB\u2010adMSC and Placebo groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Multiple intravenous infusions of autologous HB\u2010adMSCs were found to be safe and feasible in the patients with PD. Efficacy outcomes should be interpreted with caution, as this small, early\u2010phase study was not designed or powered to demonstrate definitive efficacy.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration:<\/jats:bold>\n                      ClinicalTrials.gov identifier: NCT04928287\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/padi\/9934417","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:44:26Z","timestamp":1778658266000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Multiple Intravenous Infusions of Autologous Adipose\u2010Derived Mesenchymal Stem Cells in Parkinson\u2019s Disease: A Randomized, Double\u2010Blind Clinical Trial"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-5133","authenticated-orcid":false,"given":"Ridhima","family":"Vij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1732-5774","authenticated-orcid":false,"given":"Hosu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3095-762X","authenticated-orcid":false,"given":"Hyeonggeun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8857-8517","authenticated-orcid":false,"given":"Djamchid","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-0143","authenticated-orcid":false,"given":"Thanh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6767-2676","authenticated-orcid":false,"given":"Donna","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"e_1_2_10_1_2","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-073"},{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology9050103"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.2741\/s415"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25634.1"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.3233\/jpd-171077"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148799"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0791-7"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0129"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.2217\/rme.15.17"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.03.004"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2022.103784"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718766324"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2023.05.002"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2016.10.007"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1321303"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09348-3"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1257080"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13547"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28582"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2009.07.006"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.25259\/sni_233_2020"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.131045"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x20666220201100238"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23932"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.12.048"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0377-9"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12841"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1290-8"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574888x16666210202145639"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1626996"}],"container-title":["Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/padi\/9934417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/padi\/9934417","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/padi\/9934417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:44:28Z","timestamp":1778658268000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/padi\/9934417"}},"subtitle":[],"editor":[{"given":"Semonti","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/padi\/9934417"],"URL":"https:\/\/doi.org\/10.1155\/padi\/9934417","archive":["Portico"],"relation":{},"ISSN":["2090-8083","2042-0080"],"issn-type":[{"value":"2090-8083","type":"print"},{"value":"2042-0080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2024-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9934417"}}